p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells.
D018952:Antigens, CD34; D051418:Focal Adhesion Kinase 2; D016044:Fusion Proteins, bcr-abl / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000209:etiology / Q000235:genetics / Q000473:pathology; D015466:Leukemia, Myeloid, Chronic-Phase / Q000209:etiology / Q000235:genetics / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000378:metabolism / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D012322:RNA Precursors / Q000235:genetics; D012326:RNA Splicing
D018952:Antigens, CD34; D012322:RNA Precursors; D011505:Protein-Tyrosine Kinases; D051418:Focal Adhesion Kinase 2; D016044:Fusion Proteins, bcr-abl